These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 15817712)

  • 1. Comparison of the tyrosine aminotransferase cDNA and genomic DNA sequences of normal mink and mink affected with tyrosinemia type II.
    Leib SR; McGuire TC; Prieur DJ
    J Hered; 2005; 96(4):302-9. PubMed ID: 15817712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and mutational investigations of tyrosinemia type II in Northern Tunisia: identification and structural characterization of two novel TAT mutations.
    Charfeddine C; Monastiri K; Mokni M; Laadjimi A; Kaabachi N; Perin O; Nilges M; Kassar S; Keirallah M; Guediche MN; Kamoun MR; Tebib N; Ben Dridi MF; Boubaker S; Ben Osman A; Abdelhak S
    Mol Genet Metab; 2006 Jun; 88(2):184-91. PubMed ID: 16574453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Richner-Hanhart syndrome: report of a case with a novel mutation of tyrosine aminotransferase.
    Minami-Hori M; Ishida-Yamamoto A; Katoh N; Takahashi H; Iizuka H
    J Dermatol Sci; 2006 Jan; 41(1):82-4. PubMed ID: 16318910
    [No Abstract]   [Full Text] [Related]  

  • 4. Tyrosinemia type II (Richner-Hanhart syndrome): a new mutation in the TAT gene.
    Culic V; Betz RC; Refke M; Fumic K; Pavelic J
    Eur J Med Genet; 2011; 54(3):205-8. PubMed ID: 21145993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The genetic tyrosinemias.
    Scott CR
    Am J Med Genet C Semin Med Genet; 2006 May; 142C(2):121-6. PubMed ID: 16602095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel and recurrent mutations in the TAT gene in Tunisian families affected with Richner-Hanhart syndrome.
    Bouyacoub Y; Zribi H; Azzouz H; Nasrallah F; Abdelaziz RB; Kacem M; Rekaya B; Messaoud O; Romdhane L; Charfeddine C; Bouziri M; Bouziri S; Tebib N; Mokni M; Kaabachi N; Boubaker S; Abdelhak S
    Gene; 2013 Oct; 529(1):45-9. PubMed ID: 23954227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Richner-Hanhart syndrome detected by expanded newborn screening.
    Meissner T; Betz RC; Pasternack SM; Eigelshoven S; Ruzicka T; Kruse R; Laitenberger G; Mayatepek E
    Pediatr Dermatol; 2008; 25(3):378-80. PubMed ID: 18577048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in the 4-hydroxyphenylpyruvic acid dioxygenase gene are responsible for tyrosinemia type III and hawkinsinuria.
    Tomoeda K; Awata H; Matsuura T; Matsuda I; Ploechl E; Milovac T; Boneh A; Scott CR; Danks DM; Endo F
    Mol Genet Metab; 2000 Nov; 71(3):506-10. PubMed ID: 11073718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyrosine aminotransferase deficiency in mink (Mustela vision): a model for human tyrosinemia II.
    Goldsmith LA; Thorpe JM; Marsh RF
    Biochem Genet; 1981 Aug; 19(7-8):687-93. PubMed ID: 6117279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The narrow substrate specificity of human tyrosine aminotransferase--the enzyme deficient in tyrosinemia type II.
    Sivaraman S; Kirsch JF
    FEBS J; 2006 May; 273(9):1920-9. PubMed ID: 16640556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nucleotide sequence of the human tyrosine aminotransferase gene].
    Zelenin SM; Mertvetsov NP
    Bioorg Khim; 1994 Feb; 20(2):196-204. PubMed ID: 7908801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Point mutations in the tyrosine aminotransferase gene in tyrosinemia type II.
    Natt E; Kida K; Odievre M; Di Rocco M; Scherer G
    Proc Natl Acad Sci U S A; 1992 Oct; 89(19):9297-301. PubMed ID: 1357662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Albinism in the American mink (Neovison vison) is associated with a tyrosinase nonsense mutation.
    Anistoroaei R; Fredholm M; Christensen K; Leeb T
    Anim Genet; 2008 Dec; 39(6):645-8. PubMed ID: 18822100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tyrosinemia type II. Case report].
    Benatiya AI; Bouayed MA; Touiza E; Daoudi K; Bhalil S; Elmesbahi I; Tahri H
    Bull Soc Belge Ophtalmol; 2005; (296):57-61. PubMed ID: 16050420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New forms of hereditary tyrosinemia type II in mink: hepatic tyrosine aminotransferase defect.
    Christensen K; Henriksen P; Sørensen H
    Hereditas; 1986; 104(2):215-22. PubMed ID: 2876972
    [No Abstract]   [Full Text] [Related]  

  • 16. Splicing mutations, mainly IVS6-1(G>T), account for 70% of fumarylacetoacetate hydrolase (FAH) gene alterations, including 7 novel mutations, in a survey of 29 tyrosinemia type I patients.
    Arranz JA; Piñol F; Kozak L; Pérez-Cerdá C; Cormand B; Ugarte M; Riudor E
    Hum Mutat; 2002 Sep; 20(3):180-8. PubMed ID: 12203990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyrosinemia type II: Novel mutations in TAT in a boy with unusual presentation.
    Gokay S; Kendirci M; Ustkoyuncu PS; Kardas F; Bayram AK; Per H; Poyrazoğlu HG
    Pediatr Int; 2016 Oct; 58(10):1069-1072. PubMed ID: 27285949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nucleotide sequence of rat tyrosine aminotransferase gene].
    Morozov IV; Smagulova FO; Soshnikova NV; Mertvetsov NP
    Bioorg Khim; 1999 Apr; 25(4):312-20. PubMed ID: 10422597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescence in situ hybridization and chromosomal organization of the human Sirtuin 7 gene.
    Voelter-Mahlknecht S; Letzel S; Mahlknecht U
    Int J Oncol; 2006 Apr; 28(4):899-908. PubMed ID: 16525639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel and recurrent tyrosine aminotransferase gene mutations in tyrosinemia type II.
    Hühn R; Stoermer H; Klingele B; Bausch E; Fois A; Farnetani M; Di Rocco M; Boué J; Kirk JM; Coleman R; Scherer G
    Hum Genet; 1998 Mar; 102(3):305-13. PubMed ID: 9544843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.